Acute and impaired wound healing:  pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds:  biology, causes, and approaches to care.
This is the first installment of 2 articles that discuss the biology and pathophysiology of wound healing, review the role that growth factors play in this process, and describe current ways of growth factor delivery into the wound bed. Part 1 discusses the latest advances in clinicians' understanding of the control points that regulate wound healing. Importantly, biological similarities and differences between acute and chronic wounds are considered, including the signaling pathways that initiate cellular and tissue responses after injury, which may be impeded during chronic wound healing.
E.L. Steele Laboratory of Tumor Biology, Massachusetts General Hospital, Boston, USA.
Tatiana N
TN
Demidova-Rice
Michael R
MR
Hamblin
Ira M
IM
Herman
D000890:Anti-Infective Agents / Q000627:therapeutic use; D018441:Biofilms / Q000254:growth & development; D002908:Chronic Disease; D003646:Debridement / Q000379:methods*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D015603:Keratinocytes / Q000378:metabolism*; D014945:Wound Healing / Q000502:physiology*; D014947:Wounds and Injuries / Q000145:classification / Q000503:physiopathology* / Q000628:therapy
D000890:Anti-Infective Agents; D036341:Intercellular Signaling Peptides and Proteins